FROM Ellen Matloff
Angelina Jolie, Breast Cancer and Radical Surgery In 1974, First Lady Betty Ford talked openly about her mastectomy, bringing the fears of every woman out into the open. Since then, much has changed, including the discovery of the BRCA 1 and 2 genes in 1994 and 95. This week, international super-star Angelina Jolie revealed her decision to have both breasts removed — even though she did not yet have cancer – starting a new conversation about what to do if genetic testing shows a high risk for the disease. Experts say the most important lesson is that even the testing is not for everyone, let alone a double mastectomy. There’s concern that many women will demand more treatment than they need, partly because of the "pink ribbon" culture and the medical industry. We hear more about the agonizing decisions women might be faced with all on their own.
Genetic Breakthroughs: Patents and Profits Mapping the human genome began "the biological gold rush of the 21st Century," with companies now owning patents on 4000 human genes. Today, the US Supreme Court is being asked to strike down two patents on BRCA 1 and BRCA 2, genes that helped doctors discover both breast and ovarian cancer. Nobody can do that without paying Myriad Genetics , which isolated the genes. But opponents argue the genes are "products of Nature." We hear about a case with long-term implications for the future of "personalized medicine" designed to serve the needs of each individual patient.
Replacing Obamacare: Now you see it… now you don’t As the Senate deliberates replacing Obmacare, health coverage for millions of people is at stake. There've been no public hearings, and a draft measure won't be made public. Is the House version so unpopular that that Senate is hiding a version that looks much the same?
The Trump agenda: where's the beef? President Trump says big things are happening. After celebrating a House bill on health care, he doesn’t yet have Senate agreement. With James Comey’s public testimony scheduled tomorrow, the President today tweeted his selection of a new FBI Director. Is the Chief Executive all style and no substance? Later, terror attacks in Iran and conflicting claims about who’s behind them.
Will the Senate write a healthcare bill in secret? While Democrats and Republicans argue White House relations with Russia, another question is being decided behind closed doors: who gets help buying health insurance and who doesn't? We hear how the pros and cons are being shrouded in secrecy.